C-terminus of human BKca channel alpha subunit enhances the permeability of the brain endothelial cells by interacting with caveolin-1 and triggering caveolin-1 intracellular trafficking

NeuroMolecular Medicine

Volumn 16, Issue 2, 2014, Pages 499-509

  Song, Yang ^a   Wang, Ping ^a   Ma, Jun ^a   Xue, Yixue ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

BKca; Blood tumor barrier; Caveolin 1; HBMECs; HSlo1

Indexed keywords

CAVEOLIN 1; FILIPIN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; HYBRID PROTEIN; KCNMA1 PROTEIN, HUMAN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNIT; NERVE PROTEIN;

AMINO ACID ANALYSIS; ARTICLE; BRAIN CELL; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CELL MEMBRANE PERMEABILITY; COCULTURE; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MICROVASCULAR ENDOTHELIAL CELL; PLASMID; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; BRAIN TUMOR; CAVEOLA; CELL CULTURE; CELL MEMBRANE; CHEMISTRY; DRUG EFFECTS; ENDOTHELIUM CELL; GENE DELETION; GENETICS; GLIOMA; METABOLISM; MICROVASCULATURE; PATHOLOGY; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; TUMOR CELL LINE; VASCULARIZATION;

BRAIN NEOPLASMS; CAVEOLAE; CAVEOLIN 1; CELL LINE, TUMOR; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOPLASM; ENDOTHELIAL CELLS; FILIPIN; GLIOMA; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; MICROVESSELS; NERVE TISSUE PROTEINS; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION;

EID: 84901339996     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-014-8300-3     Document Type: Article

References (36)

1. Alioua, A., Lu, R., Kumar, Y., Eghbali, M., Kundu, P., Toro, L., et al. (2008). Slo1 caveolin-binding fragment, a mechanism of caveolin-1-Slo1 interaction regulating Slo1 surface expression. Journal of Biological Chemistry, 283, 4808-4817.
2. Black, K. L., & Ningaraj, N. S. (2004). Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor. Cancer Control, 11, 165-173.
3. Black, K. L., et al. (2008). Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models. Brain Research, 1227, 198-206.
4. Brainard, A. M., Korovkina, V. P., & England, S. K. (2009). Disruption of the maxi-K-caveolin-1 interaction alters current expression in human myometrial cells. Reproductive Biology and Endocrinology, 7, 131.
5. Brainard, A. M., Miller, A. J., Martens, J. R., & England, S. K. (2005). Maxi-K channels localize to caveolae in human myometrium: a role for an actin-channel-caveolin complex in the regulation of myometrial smooth muscle K+ current. American Journal of Physiology-Cell Physiology, 289, C49-C57.
6. Cheng, X., & Jaggar, J. H. (2006). Genetic ablation of caveolin-1 modifies Ca2+ spark coupling in murine arterial smooth muscle cells. American Journal of Physiology-Heart and Circulatory Physiology, 290, H2309-H2319.
7. Cornford, E. M., & Hyman, S. (2005). Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy. NeuroRx, 2, 27-43.
8. Côté, J., et al. (2012). Induction of selective blood-tumor barrier permeability and macromolecular transport by a biostable kinin B1 receptor agonist in a glioma rat model. PLoS One, 7, e37485.
9. Daniel, E. E., Jury, J., & Wang, Y. F. (2001). nNOS in canine lower esophageal sphincter: colocalized with Cav-1 and Ca2 + -handling proteins? American Journal of Physiology-Gastrointestinal and Liver Physiology, 281, G1101-G1114.
10. Dunn, I. F., Heese, O., & Black, P. M. (2000). Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs. Journal of Neuro-oncology, 50, 121-137.
11. Frank, P. G., Woodman, S. E., Park, D. S., & Lisanti, M. P. (2003). Caveolin, caveolae, and endothelial cell function. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 1161-1168.
12. Gu, Y. T., Xue, Y. X., Wang, Y. F., Wang, J. H., ShangGuan, Q. R., Zhang, J. X., et al. (2012). Role of ROS/RhoA/PI3 K/PKB signaling in NS1619-mediated blood-tumor barrier permeability increase. Journal of Molecular Neuroscience, 48, 302-312.
13. Hu, J., et al. (2007). Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model. Molecular Cancer, 6, 22.
14. Lam, R. S., Shaw, A. R., & Duszyk, M. (2004). Membrane cholesterol content modulates activation of BK channels in colonic epithelia. Biochimica et Biophysica Acta, 1667, 241-248.
15. Liu, L. B., Xue, Y. X., & Liu, Y. H. (2010). Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway. Journal of Neuro-oncology, 99, 187-194.
16. Matveev, S., Li, X., Everson, W., & Smart, E. J. (2001). The role of caveolae and caveolin in vesicle-dependent and vesicle-independent trafficking. Advanced Drug Delivery Reviews, 49, 237-250.
17. Meera, P., Wallner, M., Song, M., & Toro, L. (1997). Large conductance voltage- and calcium-dependent K+ channel, a distinct member of voltage-dependent ion channels with seven N-terminal transmembrane segments (S0-S6), an extracellular N terminus, and an intracellular (S9-S10) C terminus. Proceedings of the National Academy of Sciences of the United States of America, 94, 14066-14071.
18. Ningaraj, N. S., Rao, M., Hashizume, K., Asotra, K., & Black, K. L. (2002). Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels. Journal of Pharmacology and Experimental Therapeutics, 301, 838-851.
19. Park, E. J., Zhang, Y. Z., Vykhodtseva, N., & McDannold, N. (2012). Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. Journal of Controlled Release, 163, 277-284.
20. Predescu, D., Vogel, S. M., & Malik, A. B. (2004). Functional and morphological studies of protein transcytosis in continuous endothelia. American Journal of Physiology-Lung Cellular and Molecular Physiology, 287, L895-L901.
21. Proescholdt, M. A., Heiss, J. D., Walbridge, S., Mühlhauser, J., Capogrossi, M. C., Oldfield, E. H., et al. (1999). Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. Journal of Neuropathology and Experimental Neurology, 58, 613-627.
22. Qin, L. J., Gu, Y. T., Zhang, H., & Xue, Y. X. (2009). Bradykinin-induced blood-tumor barrier opening is mediated by tumor necrosis factor-alpha. Neuroscience Letters, 450, 172-175.
23. Salkoff, L., Butler, A., Ferreira, G., Santi, C., & Wei, A. (2006). High-conductance potassium channels of the SLO family. Nature Reviews Neuroscience, 7, 921-931.
24. Sheikov, N., McDannold, N., Jolesz, F., Zhang, Y. Z., Tam, K., & Hynynen, K. (2006). Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood-brain barrier. Ultrasound in Medicine and Biology, 32, 1399-1409.
25. Stewart, P. A., Hayakawa, K., & Farrell, C. L. (1994). Quantitation of blood-brain barrier ultrastructure. Microscopy Research and Technique, 27, 516-527.
26. Terasaki, T., & Pardridge, W. M. (2000). Targeted drug delivery to the brain; (blood-brain barrier, efflux, endothelium, biological transport). Journal of Drug Targeting, 8, 353-355.
27. Wallner, M., Meera, P., & Toro, L. (1996). Determinant for beta-subunit regulation in high-conductance voltage-activated and Ca2+-sensitive K+ channels: an additional transmembrane region at the N terminus. Proceedings of the National Academy of Sciences of the United States of America, 93, 14922-14927.
28. Wang, X. L., Ye, D., Peterson, T. E., Cao, S., Shah, V. H., Katusic, Z. S., et al. (2005). Caveolae targeting and regulation of large conductance Ca(2+)-activated K+ channels in vascular endothelial cells. Journal of Biological Chemistry, 280, 11656-11664.
29. Weksler, B. B., et al. (2005). Blood-brain barrier-specific properties of a human adult brain endothelial cell line. The FASEB Journal, 19, 1872-1874.
30. Weyerbrock, A., Walbridge, S., Saavedra, J. E., Keefer, L. K., & Oldfield, E. H. (2011). Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas. Neuro-oncology, 13, 203-211.
31. Xie, H., Xue, Y. X., Liu, L. B., & Liu, Y. H. (2010). Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins. Brain Research, 1319, 13-20.
32. Xie, H., Xue, Y. X., Liu, L. B., Liu, Y. H., & Wang, P. (2012). Role of RhoA/ROCK signaling in endothelial-monocyte-activating polypeptide II opening of the blood-tumor barrier: Role of RhoA/ROCK signaling in EMAP II opening of the BTB. Journal of Molecular Neuroscience, 46, 666-676.
33. Yao, Y., Kubota, T., Sato, K., Kitai, R., Takeuchi, H., & Arishima, H. (2001). Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours. Acta Neurochirurgica, 143, 159-166.
34. Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., & Jain, R. K. (1996). Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proceedings of the National Academy of Sciences of the United States of America, 93, 14765-14770.
35. Zagzag, D., Miller, D. C., Sato, Y., Rifkin, D. B., & Burstein, D. E. (1990). Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Research, 50, 7393-7398.
36. Zhao, L. N., Yang, Z. H., Liu, Y. H., Ying, H. Q., Zhang, H., & Xue, Y. X. (2011). Vascular endothelial growth factor increases permeability of the blood-tumor barrier via caveolae-mediated transcellular pathway. Journal of Molecular Neuroscience, 44, 122-129.